Study of Tune-401 for chronic hepatitis B
Part of Digestive system, Infections clinical trials.
This study tests a new medicine, Tune-401, for adults with chronic hepatitis B who are already on a daily antiviral pill. The goal is to see if it is safe and can reduce the virus in your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic hepatitis B (a long-term infection with the hepatitis B virus).
- You are currently taking a daily antiviral pill for hepatitis B (like tenofovir or entecavir).
- You are between 18 and 75 years old.
- Your body mass index (BMI) is at least 18.5.
- Your liver blood tests (ALT/AST) are below 1.5 times the normal limit, and your bilirubin is normal or near normal.
- You do not have another type of liver disease besides hepatitis B (like fatty liver disease or alcoholic liver disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called GST-HG141 for people with chronic hepatitis B whose virus is still active despite taking standard antiviral pills. It aims to see if the new drug can better control the virus.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This study tests a new drug, GST-HG131, for people with chronic hepatitis B who are already on stable treatment. It aims to see if the drug is safe and reduces the virus further.
This trial tests a new medicine called EPI-003 for people with chronic hepatitis B who are already taking antiviral pills (like entecavir or tenofovir). The goal is to see if adding EPI-003 can further lower the virus and help the immune system. You must continue your current antiviral during the study.
This is a follow-up study for people with chronic hepatitis B who completed an earlier trial of GST-HG141 (a new antiviral drug) combined with standard hepatitis B medications. The study checks if this combination continues to work safely and effectively over a longer period.
This study tests whether a fungus-fighting drug, terbinafine, can help treat chronic hepatitis B. It is for people with stable disease who are not on other antivirals or are only on tenofovir.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.